Restart Life Sciences Corp.
HEAL
Rank in Stocks
#35865
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Share Price
$0.0497946
Last synced: 2026-10-20
Market Cap
$3.11M
Change (1 day)
-3.08%
Change (1 year)
73.34%
Country
CA
Trade Restart Life Sciences Corp. (HEAL)
Category
Healthcare
Stock price history for Restart Life Sciences Corp. (HEAL)
Highest end of day price: $0.02 on 2024-11-01
Lowest end of day price: $43.29 on 2006-09-01
Lowest end of day price: $43.29 on 2006-09-01
Stock price history of Restart Life Sciences Corp. from 2006 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2024 | -75.42% |
| 2023 | -70.35% |
| 2022 | 0.09% |
| 2021 | -76.14% |
| 2020 | 34.36% |
| 2019 | -45.75% |
| 2018 | -79.87% |
| 2017 | 288.11% |
| 2016 | 333.30% |
| 2015 | 1.17% |
| 2014 | -47.74% |
| 2013 | -50.83% |
| 2012 | -85.77% |
| 2011 | -17.65% |
| 2010 | -44.42% |
| 2009 | -3.55% |
| 2008 | -53.46% |
| 2007 | -59.30% |
| 2006 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $520.80 | 22.18% |
US
|
|
| $249.05 | 805.97% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $885.14 | 6.04% |
NL
|
|
| $752.87 | 7.40% |
CH
|
